Vieira Roberto Wandenkolkinsider trades
In SEC Form 4 filings, Vieira Roberto Wandenkolk is listed as President, Oncology of Corcept Therapeutics Inc (CORT). In the last 90 days, Vieira Roberto Wandenkolk sold $7.46M of Corcept Therapeutics Inc (CORT) on the open market and bought none. All 11 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CORTCorcept Therapeutics Inc | President, Oncology | 18 | Oct 5 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | M | 8,333 | $21.63 | $180,243 | 12,279 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | S | 1,100 | $114.52 | Sale −$125,973 | 11,179 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | S | 2,086 | $115.73 | Sale −$241,412 | 9,093 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | S | 5,147 | $116.59 | Sale −$600,063 | 3,946 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | M · derivative | 8,333 | $21.63 | $180,243 | 133,334 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 16 | Sep 18 | S | 296 | $100.82 | Sale −$29,843 | 3,946 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | F | 102 | $113.38 | $11,565 | 4,242 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | M | 58,333 | $21.63 | $1,261,743 | 62,575 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | S | 23,600 | $109.35 | Sale −$2,580,674 | 38,975 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | S | 23,770 | $110.70 | Sale −$2,631,349 | 15,205 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | S | 1,537 | $111.37 | Sale −$171,181 | 13,668 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | S | 974 | $112.40 | Sale −$109,474 | 12,694 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | S | 1,606 | $113.72 | Sale −$182,632 | 11,088 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | S | 5,621 | $114.58 | Sale −$644,042 | 5,467 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | S | 1,225 | $115.44 | Sale −$141,413 | 4,242 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | M · derivative | 58,333 | $21.63 | $1,261,743 | 141,667 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 1 | Sep 3 | A | 138 | $113.38 | $15,646 | 4,206 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 1 | Sep 3 | A | 138 | $0.00 | $0 | 4,344 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.